Pfizer reported positive Phase 3 results for TALZENNA (talazoparib) in combination with XTANDI in HRR gene mutated metastatic castration sensitive prostate cancer. The company plans to seek expanded ...

Aging men often lose the Y chromosome in a growing number of their cells—and it may be far more dangerous than once believed. This loss has been linked to heart disease, cancer, Alzheimer’s, and ...

His method of locating genes in human DNA allowed researchers to find disease-causing genes, and later to map the entire, ...

Mike Francisco was an athletic 35-year-old Phoenix medical professional when he was diagnosed with late-stage colon cancer. His story is not unusual.

A breakthrough in CAR-T therapy may allow cancer treatment with a single injection, cutting costs and making care more available.

This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...

Acquiring a unit of privately held Synnovation Therapeutics hands Novartis a prospect that might improve on medicines that, like its own Piqray, target tumors driven to growth by PIK3CA mutations.

Nano-therapeutics represent a transformative advancement in precision cancer medicine, offering the promise of more effective and targeted treatment options. By harnessing the unique properties of ...

The UCSF Lynch Syndrome Center is a leading Northern California clinic specializing in Lynch syndrome, a common genetic condition increasing the risk of colon cancer and other cancers. The center ...

Paul Conyngham used AI to pinpoint the mutations in his dog Rose's tumor — and used the data to have a treatment made just for her ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.